Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...

The Finnish startup’s pack can charge from 0 to 80 percent in under 5 minutes, according to its first independent test. The Finnish startup’s pack can charge from 0 to 80 percent in under 5 minutes, ...

Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, amoebic and viral pathogens presenting major diagnostic and therapeutic ...

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile—commonly known as C. diff—are a serious and persistent problem for patients and hospitals ...

The Wall Street Journal thinks it might know your reading habits — and your potential spending habits — better than you know them yourself. For the past couple of years, the Journal — home to one of ...

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile —commonly known as C. diff —are a serious and persistent problem for patients and ...

Observation: Julia Angwin and Jeff Larson left their jobs at ProPublica to “start a crazy adventure.” Hypothesis: Their recently unveiled organization, The Markup, is setting up a new model for ...

A Lyme disease blood test helps determine if you have contracted the bacteria that cause Lyme disease, which is transmitted through infected ticks. The test looks for Lyme disease-specific antibodies ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Gordon Scott has been an active investor and ...